Press releases | WebDisclosure

Basculer en Français

9804	Companies
196632	Keywords
127649	Articles
104544	Press releases

Home
Press releases

PRESS RELEASE

published on 09/11/2024 at 14:00, 1 year 4 months ago

TVM CAPITAL LIFE SCIENCE TO PARTICIPATE IN LSI EUROPE ’24 EMERGING MEDTECH SUMMIT 2024
TVM Capital Life Science to participate in LSI Europe '24 Emerging Medtech Summit 2024, showcasing partnerships and trends in healthcare technology. Key panel discussion on cross-border investors in medtech

Healthcare Technology Investment TVM Capital Life Science Medtech Summit LSI Europe '24
PRESS RELEASE

published on 09/11/2024 at 14:00, 1 year 4 months ago

Saha Global Awarded $5 Million Grant From the Conrad N. Hilton Foundation to Expand Safe Water Access in Rural Ghana
Saha Global awarded $5-million grant from Conrad N. Hilton Foundation to expand safe water access for underserved populations in Ghana

Ghana Grant Saha Global Conrad N. Hilton Foundation Safe Water Access
PRESS RELEASE

published on 09/11/2024 at 14:00, 1 year 4 months ago

illuxi Expands Its Footprint Across Canada
Illuxi, a leading provider of AI-powered learning platforms, opens new office in Toronto and appoints Vincent Bowry as National Sales and Client Success Manager, underscoring its commitment to expanding across Canada

Expansion Illuxi Toronto Office Vincent Bowry AI-powered Learning
PRESS RELEASE

published on 09/11/2024 at 14:00, 1 year 4 months ago

illuxi étend sa présence à travers le Canada
Illuxi, leader en formation par l'IA, ouvre un bureau à Toronto et nomme Vincent Bowry comme directeur des ventes et du succès client. Expansion stratégique soulignant l'engagement d'illuxi au Canada anglophone

Illuxi Toronto IA Formation Vincent Bowry
PRESS RELEASE

published on 09/11/2024 at 13:30, 1 year 4 months ago

MIRA Pharmaceuticals Designates Neuropathic Pain as Primary Indication for Ketamir-2 and Submits Pre-IND Meeting Request to FDA
MIRA Pharmaceuticals, Inc. selects neuropathic pain as the primary indication for its novel oral ketamine analog, Ketamir-2, targeting neurologic disorders. Pre-IND meeting with FDA anticipated in Nov 2024

Preclinical Studies MIRA Pharmaceuticals Ketamir-2 Neuropathic Pain FDA Meeting
PRESS RELEASE

published on 09/11/2024 at 13:30, 1 year 4 months ago

Nextech3D.ai Signs LOI to Acquire Designhubz Expanding its 3D & AR Portfolio With Try-On Technology For Wearables
Nextech3D.AI acquires Designhubz's AR try-on technology, enhancing immersive eCommerce experiences and personalization capabilities. CEO excited about the expanded market and strategic positioning

E-commerce Nextech3D.ai AR Technology Immersive Experiences Designhubz
PRESS RELEASE

published on 09/11/2024 at 13:30, 1 year 4 months ago

CallTower and Nuvias UC Launch Alliance in EMEA
CallTower partners with Nuvias UC to expand cloud communications distribution in EMEA. The collaboration aims to enhance productivity and reach new markets

Partnership Cloud Communications CallTower Nuvias UC EMEA Marketplace
PRESS RELEASE

published on 09/11/2024 at 13:30, 1 year 4 months ago

Electrical Geophysical Integration Reveals Upside at Piuquenes Cu–Au Porphyry Project, San Juan
Pampa Metals Corp. provides update on Piuquenes Cu-Au Project in Argentina, highlighting key findings from geophysical data integration and current activities for the upcoming field season

Pampa Metals Corp. Geophysical Data Argentina Field Season Piuquenes
PRESS RELEASE

published on 09/11/2024 at 13:25, 1 year 4 months ago

Hardman & Co Research on Shield Therapeutics (STX): Focusing on successful execution
Hardman & Co Research provides analysis on Shield Therapeutics (STX) focusing on successful execution. Shield progressing well with sales traction and cost control, aiming for cashflow-break even in 2H'25

Hardman & Co Research Shield Therapeutics Iron Deficiency Successful Execution Sales Traction
PRESS RELEASE

published on 09/11/2024 at 13:00, 1 year 4 months ago

Santé Canada approuve (Pr)CABTREO(MC) (phosphate de clindamycine, adapalène et peroxyde de benzoyle), un traitement topique à triple combinaison pour l'acné vulgaire chez les patients âgés de 12 ans et plus
Bausch Health Canada Inc. annonce l'approbation par Santé Canada de PrCABTREO, traitement topique à triple combinaison pour l'acné vulgaire. Disponible Q4 2024

Bausch Health Efficacité Santé Canada Traitement Topique Acné Vulgaire

Accesswire

Published on 02/04/2026 at 18:00, 3 hours 17 minutes ago

Lithium South AGSM Update
Published on 02/04/2026 at 16:15, 5 hours 2 minutes ago

Trans Canada Gold Enters into an Option Agreement with Bear Mountain Gold Mines to Acquire a 60% Interest in the Harrison Lake District Scale Gold Property, with $10.0 Million Dollars in Prior Exploration Expenditures
Published on 02/04/2026 at 15:45, 5 hours 32 minutes ago

Patriot.Tv's Jd Rucker Explains Billie Eilish's Comments on ICE, Offers ICE Commentary as Exhibit A of Celebrity Sound Bite Politics
Published on 02/04/2026 at 15:00, 6 hours 17 minutes ago

Karbon-X Files Quarterly Report on Form 10-Q Highlighting Strong Revenue Growth and Commercial Scale
Published on 02/04/2026 at 14:30, 6 hours 47 minutes ago

Datametrex Expands Business In Data Centres

View all ACCESSWIRE

EQS Group

Published on 02/04/2026 at 20:54, 23 minutes ago

Elmos Semiconductor SE is planning to distribute 36 million Euro to shareholders for the fiscal year 2025
Published on 02/04/2026 at 20:36, 41 minutes ago

EQS-Adhoc: Elmos Semiconductor SE approves share buyback program via the stock exchange of 10 million Euro and dividend proposal of 1.50 Euro per share for fiscal year 2025
Published on 02/04/2026 at 20:00, 1 hour 17 minutes ago

Belgium's Ingmar De Vos elected to Executive Board of International Olympic Committee
Published on 02/04/2026 at 18:55, 2 hours 22 minutes ago

Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/04/2026 at 18:40, 2 hours 37 minutes ago

Robin Zeng: Unlocking the Sustainable Energy Era with Zero-Carbon Technology

Les Echos

Published on 02/04/2026 at 18:04, 3 hours 13 minutes ago

Capital et droits de vote au 31 janvier 2026
Published on 02/04/2026 at 18:04, 3 hours 13 minutes ago

Total number of voting rights and shares making up the share capital at January 31, 2026
Published on 02/04/2026 at 17:45, 3 hours 32 minutes ago

Information concerning the total number of voting rights and shares 2026 01 31
Published on 02/04/2026 at 17:45, 3 hours 32 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 02/04/2026 at 17:45, 3 hours 32 minutes ago

Janvier 2026

View all LES ECHOS COMFI WIRE